For investors who aren't fully convinced that the U.S. is on the cusp of a jobs boom, On Assignment (ASGN - Get Report) is a more conservative play. The company provides staffing in health care, biotech research, engineering and other niches that aren't economically sensitive. That focus is what the company calls the "math and science" niche.
Management tends to downplay expectations as evidenced by the fact that On Assignment has topped EPS estimates by at least 14% for four straight quarters. This staffing firm will release quarterly results on Feb. 14, and if history is any guide, an upside surprise may be in the offing.
Twitter and become a fan on Facebook.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts